These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9359684)

  • 1. NF-kappaB and bone: the breaking point.
    Abu-Amer Y; Tondravi MM
    Nat Med; 1997 Nov; 3(11):1189-90. PubMed ID: 9359684
    [No Abstract]   [Full Text] [Related]  

  • 2. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling.
    Grigoriadis AE; Wang ZQ; Cecchini MG; Hofstetter W; Felix R; Fleisch HA; Wagner EF
    Science; 1994 Oct; 266(5184):443-8. PubMed ID: 7939685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.
    Iotsova V; Caamaño J; Loy J; Yang Y; Lewin A; Bravo R
    Nat Med; 1997 Nov; 3(11):1285-9. PubMed ID: 9359707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage.
    Khapli SM; Mangashetti LS; Yogesha SD; Wani MR
    J Immunol; 2003 Jul; 171(1):142-51. PubMed ID: 12816992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPAR gamma: ally and foe in bone metabolism.
    Wahli W
    Cell Metab; 2008 Mar; 7(3):188-90. PubMed ID: 18316021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genipin inhibits RANKL-induced osteoclast differentiation through proteasome-mediated degradation of c-Fos protein and suppression of NF-κB activation.
    Lee CH; Kwak SC; Kim JY; Oh HM; Rho MC; Yoon KH; Yoo WH; Lee MS; Oh J
    J Pharmacol Sci; 2014; 124(3):344-53. PubMed ID: 24646621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.
    Kanatani M; Sugimoto T; Sowa H; Kobayashi T; Kanzawa M; Chihara K
    J Cell Physiol; 2004 Oct; 201(1):17-25. PubMed ID: 15281085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis.
    Novack DV; Yin L; Hagen-Stapleton A; Schreiber RD; Goeddel DV; Ross FP; Teitelbaum SL
    J Exp Med; 2003 Sep; 198(5):771-81. PubMed ID: 12939342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis with increased osteoclastogenesis in hematopoietic cell-specific STAT3-deficient mice.
    Zhang Z; Welte T; Troiano N; Maher SE; Fu XY; Bothwell AL
    Biochem Biophys Res Commun; 2005 Mar; 328(3):800-7. PubMed ID: 15694417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rel/NF-kappaB/IkappaB proteins and cancer.
    Gilmore TD; Koedood M; Piffat KA; White DW
    Oncogene; 1996 Oct; 13(7):1367-78. PubMed ID: 8875974
    [No Abstract]   [Full Text] [Related]  

  • 11. Apolipoprotein E plays crucial roles in maintaining bone mass by promoting osteoblast differentiation via ERK1/2 pathway and by suppressing osteoclast differentiation via c-Fos, NFATc1, and NF-κB pathway.
    Noguchi T; Ebina K; Hirao M; Otsuru S; Guess AJ; Kawase R; Ohama T; Yamashita S; Etani Y; Okamura G; Yoshikawa H
    Biochem Biophys Res Commun; 2018 Sep; 503(2):644-650. PubMed ID: 29906458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esculetin attenuates receptor activator of nuclear factor kappa-B ligand-mediated osteoclast differentiation through c-Fos/nuclear factor of activated T-cells c1 signaling pathway.
    Baek JM; Park SH; Cheon YH; Ahn SJ; Lee MS; Oh J; Kim JY
    Biochem Biophys Res Commun; 2015 May; 461(2):334-41. PubMed ID: 25887803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos.
    He L; Lee J; Jang JH; Lee SH; Nan MH; Oh BC; Lee SG; Kim HH; Soung NK; Ahn JS; Kim BY
    Bone; 2012 Jun; 50(6):1207-13. PubMed ID: 22484180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
    Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
    Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
    Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
    J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of osteoclastogenic differentiation by Ikarisoside A in RAW 264.7 cells via JNK and NF-kappaB signaling pathways.
    Choi HJ; Park YR; Nepal M; Choi BY; Cho NP; Choi SH; Heo SR; Kim HS; Yang MS; Soh Y
    Eur J Pharmacol; 2010 Jun; 636(1-3):28-35. PubMed ID: 20353769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Required and nonessential functions of nuclear factor-kappa B in bone cells.
    Boyce BF; Xing L; Franzoso G; Siebenlist U
    Bone; 1999 Jul; 25(1):137-9. PubMed ID: 10423039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycyrrhizae Radix Inhibits Osteoclast Differentiation by Inhibiting c-Fos-Dependent NFATc1 Expression.
    Rho TW; Lee SY; Han SY; Kim JH; Lee KH; Kim DS; Kwak HB; Kim YK
    Am J Chin Med; 2017; 45(2):283-298. PubMed ID: 28231743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF kappa B/I kappa B proteins. Their role in cell growth, differentiation and development. Madrid, Spain, July 7-10, 1996.
    Siebenlist U
    Biochim Biophys Acta; 1997 Feb; 1332(1):R7-13. PubMed ID: 9061013
    [No Abstract]   [Full Text] [Related]  

  • 20. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
    Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.